Recruitment of collagenolytic enzyme-expressing immune cells in the CRC TME might influence the bioavailability of ECM-immobilized angiogenic factors such as VEGF, as reported in other tumor context (75, 76). Here, VEGFA is linked to colorectal carcinoma.